top of page
colab.oratory
CART
PRECISION MEDICINE
CRISIS TO CATALYST
BIOSIMILARS
COLAB.CONVERSATIONS
colabXchange
precision medicine think tank
co.laterals
co.llective
colab
co(ntext)
colab(orate)
co(mmentary)
we are not here to fit in
HOME
co(ntext)
colab.oratory
CART
PRECISION MEDICINE
precision medicine think tank
CRISIS TO CATALYST
PATIENT CENTRIC APPROACH TO HTA
COLAB.CONVERSATIONS
co.laterals
co.llective
co(mmentary)
colab(orate)
DESIGNED FOR
SYSTEMS CHANGE
the cancer collaborative
is a catalyst for change — where disruptive ideas and creative strategy come together to challenge systems, influence policy, and drive real impact for people affected by cancer.
All Posts
science
policy
advocacy
Search
The cost of inaction (on cancer)
Apr 4, 2024
4 min read
SEX BASED DATA IN HEALTHCARE. DOES IT MATTER?
Feb 11, 2024
5 min read
the true cost of the economic burden of cancer in canada
Jun 6, 2023
5 min read
flipping the script. putting the U in value frameworks
Jun 1, 2023
3 min read
Project Orbis. Accelerating time to patient access?
Mar 7, 2023
3 min read
Canadians with cancer are asking “where is cancer?” in the proposed healthcare plan anno
Feb 8, 2023
3 min read
Ontario introduces biosimilars switching policy
Jan 24, 2023
2 min read
the patented medicines review board has lost its way (again)
Nov 8, 2022
11 min read
open letter: let’s put cancer at the top of the agenda
Nov 7, 2022
1 min read
Cancer deaths must not be a side effect of the pandemic: delays in cancer diagnosis and treatment co
May 25, 2022
3 min read
improving access to innovative therapies
Nov 17, 2020
1 min read
biosimilars can significantly reshape access to innovative cancer therapies
Feb 7, 2020
0 min read
can real world evidence [RWE] really transform healthcare
Jan 27, 2020
3 min read
canadian institute for health information [CIHI] publishes drug spending statistics
Jan 13, 2020
1 min read
the future of healthcare is personalized
Nov 30, 2019
2 min read
war on cancer2019—celebrating success, accelerating progress
Nov 25, 2019
2 min read
biosimilars are not just a cost saving opportunity but the opportunity to create a more sustainable
Aug 29, 2019
2 min read
biosimilars. the european experience
Jun 21, 2019
3 min read
cancer injustice is not a science problem, a technology problem, or a genetics problem. it’s a
Jun 11, 2019
3 min read
biosimilars. past talk to action
May 30, 2019
2 min read
colab.oratory
CART
PRECISION MEDICINE
CRISIS TO CATALYST
BIOSIMILARS
COLAB.CONVERSATIONS
colabXchange
precision medicine think tank
co.laterals
co.llective
co(ntext)
colab(orate)
co(mmentary)
CO
LAB
bottom of page